BR112014032583B1 - Forma farmacêutica para liberação prolongada de substâncias ativas e seu processo de produção - Google Patents

Forma farmacêutica para liberação prolongada de substâncias ativas e seu processo de produção Download PDF

Info

Publication number
BR112014032583B1
BR112014032583B1 BR112014032583-9A BR112014032583A BR112014032583B1 BR 112014032583 B1 BR112014032583 B1 BR 112014032583B1 BR 112014032583 A BR112014032583 A BR 112014032583A BR 112014032583 B1 BR112014032583 B1 BR 112014032583B1
Authority
BR
Brazil
Prior art keywords
active substance
pharmaceutical form
emulsifier
compartment
weight
Prior art date
Application number
BR112014032583-9A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112014032583A2 (pt
BR112014032583A8 (pt
Inventor
Gernot Francas
Karl-Heinz Przyklenk
Original Assignee
Hennig Arzneimittel Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hennig Arzneimittel Gmbh & Co. Kg filed Critical Hennig Arzneimittel Gmbh & Co. Kg
Publication of BR112014032583A2 publication Critical patent/BR112014032583A2/pt
Publication of BR112014032583A8 publication Critical patent/BR112014032583A8/pt
Publication of BR112014032583B1 publication Critical patent/BR112014032583B1/pt

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112014032583-9A 2012-06-25 2013-06-24 Forma farmacêutica para liberação prolongada de substâncias ativas e seu processo de produção BR112014032583B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102012105512.2A DE102012105512A1 (de) 2012-06-25 2012-06-25 Arzneiform zur verlängerten Freisetzung von Wirkstoffen
DE102012105512.2 2012-06-25
PCT/EP2013/063163 WO2014001268A1 (de) 2012-06-25 2013-06-24 Arzneiform zur verlängerten freisetzung von wirkstoffen

Publications (3)

Publication Number Publication Date
BR112014032583A2 BR112014032583A2 (pt) 2017-06-27
BR112014032583A8 BR112014032583A8 (pt) 2021-06-22
BR112014032583B1 true BR112014032583B1 (pt) 2022-05-17

Family

ID=48670585

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014032583-9A BR112014032583B1 (pt) 2012-06-25 2013-06-24 Forma farmacêutica para liberação prolongada de substâncias ativas e seu processo de produção

Country Status (22)

Country Link
EP (1) EP2863891B1 (https=)
KR (1) KR102160837B1 (https=)
AU (1) AU2013283474B2 (https=)
BR (1) BR112014032583B1 (https=)
CA (1) CA2876294C (https=)
CO (1) CO7240370A2 (https=)
DE (1) DE102012105512A1 (https=)
EA (2) EA035815B1 (https=)
ES (1) ES2817248T3 (https=)
HR (1) HRP20201534T1 (https=)
HU (1) HUE050945T2 (https=)
IL (1) IL236465B (https=)
IN (1) IN2014MN02511A (https=)
LT (1) LT2863891T (https=)
MX (1) MX371143B (https=)
PH (1) PH12014502834B1 (https=)
PL (1) PL2863891T3 (https=)
PT (1) PT2863891T (https=)
RS (1) RS60872B1 (https=)
SI (1) SI2863891T1 (https=)
UA (1) UA116776C2 (https=)
WO (1) WO2014001268A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
HUE043399T2 (hu) 2014-06-26 2019-08-28 Hennig Arzneimittel Gmbh&Co Kg Gyógyszer, különbözõ okokból eredõ szédülés kezelésére
CA2955229C (en) 2014-07-17 2020-03-10 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
KR101625344B1 (ko) * 2015-12-21 2016-06-08 주식회사 유영제약 세레콕시브 및 둘록세틴을 함유하는 약제학적 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs
DE69811233T2 (de) * 1997-10-27 2003-11-20 Merck Patent Gmbh Feste lösungen und dispersionen von eines schlecht wasserlöslichen wirkstoffes
US6368622B2 (en) * 1999-01-29 2002-04-09 Abbott Laboratories Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
ATE500819T1 (de) * 2003-12-31 2011-03-15 Bend Res Inc Stabilisierte pharmazeutische feste zusammensetzungen von arzneimitteln mit geringer löslichkeit, poloxameren und stabilisierenden polymeren
US20050281876A1 (en) * 2004-06-18 2005-12-22 Shun-Por Li Solid dosage form for acid-labile active ingredient
DE102005014141B4 (de) * 2005-03-23 2006-12-21 Hennig Arzneimittel Gmbh & Co. Kg Tablettenförmige Retardzubereitung gegen Schwindel
US20070135435A1 (en) 2005-11-02 2007-06-14 Xiangping Qian Certain chemical entities, compositions, and methods
WO2007086078A2 (en) * 2006-01-30 2007-08-02 Panacea Biotec Ltd. Novel pharmaceutical compositions and process of preparation thereof
CN101049309A (zh) * 2006-04-03 2007-10-10 陈茜 桂利嗪滴丸及其制备方法
DK2200588T3 (da) * 2007-09-25 2019-07-01 Solubest Ltd Sammensætninger, som omfatter lipofile aktive forbindelser, og fremgangsmåde til fremstilling deraf
AU2008334580A1 (en) * 2007-12-12 2009-06-18 Basf Se Salts of active ingredients with polymeric counter-ions
WO2010142456A1 (en) * 2009-06-11 2010-12-16 Photocure Asa Solid compositions comprising 5-aminolevulinic acid
WO2011024029A1 (en) * 2009-08-24 2011-03-03 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Fast disintegrating dosage forms of cinnarizine and dimenhydrinate combination
DE102011051304A1 (de) * 2011-06-24 2012-12-27 Hennig Arzneimittel Gmbh & Co. Kg Wirkstoffmatrix
DE102011051308A1 (de) * 2011-06-24 2012-12-27 Hennig Arzneimittel Gmbh & Co. Kg Herstellungsverfahren und Arzneiform
DE102011053068A1 (de) * 2011-08-29 2013-02-28 Hennig Arzneimittel Gmbh & Co. Kg Darreichungsform mit stabilisierten Wirkstoffpartikeln

Also Published As

Publication number Publication date
AU2013283474B2 (en) 2017-12-14
PL2863891T3 (pl) 2021-01-25
CO7240370A2 (es) 2015-04-17
MX371143B (es) 2020-01-20
EP2863891A1 (de) 2015-04-29
UA116776C2 (uk) 2018-05-10
KR102160837B1 (ko) 2020-09-29
EA035815B1 (ru) 2020-08-14
IN2014MN02511A (https=) 2015-07-17
HUE050945T2 (hu) 2021-01-28
HRP20201534T1 (hr) 2021-02-19
EA028064B1 (ru) 2017-10-31
BR112014032583A2 (pt) 2017-06-27
EP2863891B1 (de) 2020-08-26
AU2013283474A1 (en) 2015-01-29
KR20150041612A (ko) 2015-04-16
SI2863891T1 (sl) 2020-11-30
IL236465B (en) 2020-06-30
LT2863891T (lt) 2020-12-10
WO2014001268A1 (de) 2014-01-03
ES2817248T3 (es) 2021-04-06
CA2876294A1 (en) 2014-01-03
RS60872B1 (sr) 2020-11-30
CA2876294C (en) 2020-09-08
EA201500043A1 (ru) 2015-09-30
PH12014502834A1 (en) 2015-02-02
BR112014032583A8 (pt) 2021-06-22
PH12014502834B1 (en) 2019-12-04
PT2863891T (pt) 2020-09-25
MX2014015642A (es) 2015-08-05
EA201792143A1 (ru) 2018-05-31
DE102012105512A1 (de) 2014-04-24
IL236465A0 (en) 2015-02-26

Similar Documents

Publication Publication Date Title
Ratnaparkhi et al. Sustained release oral drug delivery system-an overview
JP7191385B2 (ja) 特定の胃腸部位での制御放出の剤形
BR112014032583B1 (pt) Forma farmacêutica para liberação prolongada de substâncias ativas e seu processo de produção
JP5674666B2 (ja) 崩壊性粒子組成物及び口腔内速崩壊錠
Gopalakrishnan et al. Floating drug delivery systems: a review
JP5674667B2 (ja) 崩壊性粒子組成物及び口腔内速崩壊錠
US20100080847A1 (en) Medicinal compositions quickly disintegrating in the oral cavity and process for producing the same
US11839684B2 (en) Mucoadhesive pharmaceutical composition and preparation method therefor
AU2013290875A1 (en) Gastro-retentive drug delivery system
CN101927002A (zh) 一种药物涂层组合物
Thakur et al. Floating drug delivery system.
Thulluru et al. Sublingual tablets-an updated review
CA2895609C (en) Monolithic dosage form for modified release of a combination of active ingredients
Gahiwade et al. Formulation and in-vitro evaluation of trifluoperazine hydrochloride bi-layer floating tablet
Mohammed et al. Formulation Development and Evaluation Bilayer Floating Sustained and Immediate Release Tablet of Verapamil Hydrochloride by Direct Compression Method
Bhaskar et al. A REVIEW ON FORMULATION APPROACHES IN IMMEDIATE RELEASE TABLET.
KR101593911B1 (ko) 높은 경도를 갖는 속붕정 및 이의 제조 방법
CA2987114C (en) Method of 3d printing oral dosage forms having a drug in a compartment sealed by an erodible plug
Rajput¹ et al. Formulation Of The Tablets
Rasheed et al. INTERNATIONAL JOURNAL OF PHARMA WORLD RESEARCH

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/06/2013, OBSERVADAS AS CONDICOES LEGAIS